Geriatrics addresses the health needs of older adults, focusing on frailty, dementia, falls, and chronic disease management.
Send us all your questions or requests, and our expert team will assist you.
The landscape of pulmonary disease treatment has evolved from mere symptom relief to targeted disease modification. Management strategies are now highly personalized, integrating pharmacological advances with technological innovations. The goal is to stabilize the disease, reduce exacerbations, and improve the patient’s quality of life.
Treatment is rarely a single pill; it is a comprehensive regimen. This includes inhaled therapies, systemic medications, physical rehabilitation, and in severe cases, surgical intervention. Patient adherence and technique are as critical as the medication itself.
Inhaled therapy is the cornerstone of treating airway diseases. Delivering medication directly to the lungs minimizes systemic side effects and maximizes local efficacy. There are various devices: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Soft Mist Inhalers.
Correct technique is vital. A significant percentage of patients misuse their inhalers, leading to poor control. Modern smart inhalers now connect to apps to track usage and ensure proper technique.
These medications relax the muscles that tighten the airways, effectively opening them. They are classified as short acting (rescue) or long acting (maintenance). Beta agonists and anticholinergics are the two main classes.
For COPD and asthma, long acting bronchodilators (LABA and LAMA) are used daily to keep airways patent. Short acting agents (SABA) provide immediate relief during sudden shortness of breath.
Inflammation is the underlying driver of asthma and many COPD phenotypes. Inhaled steroids are potent anti-inflammatory agents that reduce swelling and mucus production in the airways.
Regular use of ICS is crucial for asthma control, preventing attacks before they start. In COPD, they are often combined with bronchodilators for patients with a history of frequent exacerbations.
For severe asthma that does not respond to standard inhalers, biologic therapies have revolutionized care. These are monoclonal antibodies (injectables) that target specific immune pathways, such as eosinophils or IgE antibodies.
By blocking specific inflammatory molecules (like IL 5 or IL 4), biologics can dramatically reduce attack rates and reliance on oral steroids. This represents the era of “precision medicine” in pulmonology.
Until recently, there was no treatment for Idiopathic Pulmonary Fibrosis (IPF). Now, antifibrotic drugs (like nintedanib and pirfenidone) can slow the progression of scarring.
While they do not reverse existing damage, they preserve lung function for longer. These medications work by inhibiting the growth factors that cause fibroblast proliferation and collagen deposition.
When the lungs can no longer transfer enough oxygen to the blood, supplemental oxygen is required. Long-term oxygen therapy (LTOT) has been proven to prolong survival in COPD patients with severe resting hypoxemia.
Modern oxygen concentrators are portable and quiet, allowing patients to maintain mobility. Therapy is prescribed based on specific blood oxygen targets, not just symptoms.
Pulmonary rehab is a comprehensive program combining supervised exercise, education, and nutritional counseling. It is one of the most effective non pharmacological interventions for chronic lung disease.
It breaks the “cycle of deconditioning” where patients avoid activity due to breathlessness, which leads to weaker muscles and more breathlessness. Rehab trains the muscles to use oxygen more efficiently.
For patients who retain carbon dioxide (hypercapnic respiratory failure), simply giving oxygen is not enough. Non Invasive Ventilation (like BiPAP) uses a mask to provide positive pressure, helping the patient take deeper breaths and exhale CO2.
NIV is used acutely in hospitals to avoid intubation and chronically at home for patients with severe COPD or obesity hypoventilation syndrome.
For conditions like Bronchiectasis and Cystic Fibrosis, clearing mucus is the primary goal. Specialized devices (like flutter valves or PEP devices) use vibration and pressure to loosen mucus.
High-frequency chest wall oscillation vests vibrate the chest to mobilize secretions. These physical therapies are essential to prevent recurrent infections caused by stagnant mucus.
This subspecialty uses minimally invasive endoscopic techniques to treat lung problems. Procedures include placing valves in airways to treat severe emphysema (Lung Volume Reduction) or using heat to reduce smooth muscle in asthma (Bronchial Thermoplasty).
Stents can be placed to keep airways open if compressed by tumors. These procedures offer options for patients who are not candidates for major surgery.
In severe emphysema, the lungs are overinflated and inefficient. LVRS involves surgically removing the most damaged parts of the lung. This allows the remaining, healthier lung tissue to expand and function better.
It improves the mechanics of the diaphragm and chest wall. While effective for selected patients, it is a major surgery with significant risks.
For end stage pulmonary disease where all other therapies have failed, lung transplantation is the final option. It can involve a single lung or double lung transplant.
It is a high-risk, high reward procedure requiring lifelong immunosuppression. Survival rates have improved, but donor organ availability remains a significant limitation.
Acute flare ups or exacerbations punctuate chronic lung diseases. Prompt treatment with systemic steroids and antibiotics is crucial to prevent permanent lung function loss.
Action plans are developed so patients know exactly what to do when symptoms worsen. Early intervention often prevents hospitalization.
Send us all your questions or requests, and our expert team will assist you.
Generally, no. Maintenance inhalers are designed to prevent symptoms, not just fix them. If you feel better, it means the medicine is working. Stopping it often leads to a gradual return of inflammation and a risk of a severe flare-up. Always consult your doctor.
No, this is a myth. Using supplemental oxygen does not make your lungs “lazy” or dependent. It provides the necessary fuel for your body’s organs when your lungs cannot do it alone. It protects your heart and brain.
A rescue inhaler (usually blue, like Albuterol) acts quickly to open airways during an attack. It wears off in a few hours. A “controller” inhaler acts slowly over 12 to 24 hours to reduce inflammation. You should rely on the controller, not the rescue.
Systemic (pill) steroids have significant side effects like weight gain, bone loss, and diabetes if taken long term. Inhaled steroids are much safer because the dose is tiny and goes directly to the lungs, with very little entering the bloodstream.
Rehab doesn’t fix the lung tissue, but it does fix the muscles by using oxygen. Stronger leg and arm muscles require less oxygen to work. This makes you feel less out of breath for the same amount of activity.
Your Comparison List (you must select at least 2 packages)
